ESC 365 - Early CSWT relieves myocardial fibrosis by inhibiting TGF-Smad2/3-MMP-9

ESC Professional Premium Access

Early CSWT relieves myocardial fibrosis by inhibiting TGF-Smad2/3-MMP-9

Session: Experimental studies in coronary atherosclerosis disease

Topic: Nonpharmacological Treatment

Speaker: Professor Y. Wang (Kunming, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Yu Wang

1st Affiliated Hospital of Kunming Medical University, Kunming (China)

0 follower

3 more presentations in this session

Coronary artery disease ameliorates extracellular vesicle lncRNA PUNISHER regulates angiogenic response and endothelial cells function via NFkB-dependent mechanism

Speaker: Doctor M. Hosen (Bonn, DE)

Role of Galectin-3 in resident macrophages and effects on atherosclerosis

Speaker: Miss Y. Li (Munich, DE)

Association of ethanolamine desaturase TMEM189-plasmalogen axis with the stability of atherosclerotic plaque and cardiovascular events after acute coronary syndrome

Speaker: Associate Professor H. Yu (Beijing, CN)

Access the full session

Experimental studies in coronary atherosclerosis disease

Speakers: Professor Y. Wang, Doctor M. Hosen, Miss Y. Li, Associate Professor H. Yu

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources